Abbonarsi

Polysaccharides from Platycodon grandiflorus attenuates high-fat diet induced obesity in mice through targeting gut microbiota - 13/09/23

Doi : 10.1016/j.biopha.2023.115318 
Weixin Ke a, b, c, Kate Jade Flay d, Xiaoning Huang e, Xiaosong Hu f, Fang Chen f, Chunbao Li a, b, c, Dan Aaron Yang g,
a College of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China 
b National Center of Meat Quality and Safety Control, Nanjing 210095, China 
c National Key Laboratory of Meat Quality Control and New Resource, Nanjing Agricultural University, Nanjing 210095, China 
d Department of Veterinary Clinical Sciences, City University of Hong Kong, Kowloon 999077, Hong Kong Special Administrative Region of China 
e Department of bioengineering, University of Illinois at Urbana, Champaign 61801, USA 
f National Engineering Research Center for Fruit and Vegetable Processing, Key Laboratory of Fruit and Vegetable Processing, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China 
g College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China 

Corresponding author.

Abstract

The root of Platycodon grandiflorus (PG), abundant in soluble polysaccharides, has a long history in traditional Asian diets and herbal medicine due to its anti-inflammatory activity and anti-obesity effects. Our previous study was the first to establish a link between the beneficial effects of PG and changes in the gut microbiota, and suggested potential roles that the polysaccharide components play. However, more evidence was needed to understand the anti-obesity functions of polysaccharides from PG (PS) and their relationship with the regulation of the gut microbiota. In this study, we first performed an experiment to explore the anti-obesity activities of PS: Male C57BL/6 mice (six-weeks-old) were fed either a standard control diet (CON), or a high-fat diet (HFD) to induce obesity, or a HFD supplemented with PS (HFPS) for 8 weeks. Body weight and food intake were monitored throughout. Lipid metabolism were determined and related gene expression changes in adipose tissues were analyzed by RNA-seq. Amplicon sequencing of the bacterial 16 S rRNA gene was used to explore gut microbiota structure in fecal samples. Then, we performed the second experiment to explore whether the anti-obesity activities of PS were dependent on the regulation of the gut microbiota: Male C57BL/6 mice (six-weeks-old), treated with an antibiotic cocktail to reduce the gut microbial load, were fed either a HFD (A-HFD) or a HFPS (A-HFPS) diet for 8 weeks. Finally, we used in vitro fermentation experiments to verify the effects of PS on the growth and metabolic activities of the gut microbes. We found that PS significantly reduced HFD-induced weight gain and excessive fat accumulation, changed the expression of key genes involved in lipid metabolism, and attenuated HFD-induced changes in the gut microbiota. However, PS did not affect fat accumulation or lipid metabolism in the gut microbiota depleted mice. Overall, our results show that PS has significant effects on the gut microbiota in the mouse model, and the anti-obesity effects of PS are mediated via changes in the gut microbiota composition and metabolic activity.

Il testo completo di questo articolo è disponibile in PDF.

Graphical Abstract




ga1

Il testo completo di questo articolo è disponibile in PDF.

Highlights

PS reduced body weight and fat accumulation in mice fed a high-fat diet.
PS regulated the expression of lipid-metabolic genes in adipose tissue of mice.
PS effectively prevented HFD-induced dysbiosis in the gut microbiota of mice.
The observed beneficial effects of PS relied on a healthy gut microbiota.
In vitro, PS boosted beneficial gut bacteria, increasing SCFAs production.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : PG, PS, HFD, CON, HFPP, TG, TC, HDL, LDL, WAT, OTUs, PCA, LEfSe, LDA, PPAR-γ, SCFAs

Keywords : Obesity, High-fat diet, PPAR signaling pathway, Gut microbiota, Antibiotic treatment


Mappa


© 2023  The Authors. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 166

Articolo 115318- ottobre 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • Multi-omics reveals aspirin eugenol ester alleviates neurological disease
  • Qi Tao, Zhen-Dong Zhang, Xiao-Rong Lu, Zhe Qin, Xi-Wang Liu, Shi-Hong Li, Li-Xia Bai, Bo-Wen Ge, Jian-Yong Li, Ya-Jun Yang
| Articolo seguente Articolo seguente
  • Cubosomes-assisted transdermal delivery of doxorubicin and indocyanine green for chemo-photothermal combination therapy of melanoma
  • Zhenzhen Chen, Qinbiao Huang, Yutong Song, Xianquan Feng, Lingjun Zeng, Zhihong Liu, Xiaomu Hu, Chun Tao, Lie Wang, Yafeng Qi, Hongtao Song

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.